Name(Required)

Q1. HA filler is cross-linked with which agent to increase durability from hours to months?(Required)

A. Sodium hyaluronate

B. BDDE (butanediol diglycidyl ether)

C. Vitamin C

D. Lidocaine HCl EXPLANATION: BDDE

Q2. What is G-prime (G') in filler rheology, and why does it matter clinically?(Required)

A. Concentration of lidocaine -- higher G' means more pain relief

B. Elastic modulus/stiffness -- higher G' = more lift and projection; lower G' = softer spread

C. The pH of the product -- affects patient comfort

D. The particle size -- larger G' means slower degradation

Q3. What is the critical safety difference between Radiesse and HA fillers?(Required)

A. Radiesse lasts only 3 months and must be used carefully

B. Radiesse cannot be placed in the lips and is NOT reversible with hyaluronidase

C. Radiesse requires pre-treatment allergy testing

D. Radiesse must be refrigerated within 4 hours of opening

Q4. Where should volume be RESTORED FIRST in an aging face per the Triangle of Youth concept?(Required)

A. Superficial fat pads -- nasolabial folds and jowls

B. The lips -- perioral volume creates youthful appearance

C. Deep compartments first -- SOOF and deep medial cheek fat -- to restore the midface scaffold

D. The forehead -- brow lifting is the primary age reversal target

Q5. A patient develops immediate blanching in the NLF during filler injection. What does this indicate?(Required)

A. Normal vascular compression -- continue slowly

B. Vascular occlusion -- stop immediately, massage, apply warmth, inject hyaluronidase at high dose

C. Filler too superficial -- reposition and inject deeper

D. Vasovagal response -- have patient breathe slowly and continue

Q6. Which statement is TRUE about Sculptra (PLLA)?(Required)

A. Sculptra provides immediate volume visible the same day

B. culptra is reversible with hyaluronidase in an emergency

C. Sculptra is a biostimulator -- gradual collagen production over 4-6 weeks; NOT a filler

D. Sculptra requires only one treatment session for full effect

Q7. The RHA Collection is designed specifically for which treatment zone?(Required)

A. Static volume restoration -- temple and cheek only

B. Dynamic facial zones with constant movement -- perioral, nasolabial, lips

C. Deep bone-level augmentation -- mandibular contouring only

D. Periorbital tear trough -- lowest G' product in HA range

Q8. Which filler product received FDA approval in February 2025 using Cold-X technology?(Required)

A. Restylane Lyft

B. Juvederm Voluma XC C Evolysse Smooth and

C. Evolysse Smooth and Evolysse Form

D. Belotero Volume

Q9. For maximum structural cheek lift, which filler property is most important to select?

A. Lowest G-prime -- softest product for natural movement

B. Highest G-prime (high elastic modulus) -- maximum lift and projection

C. Lowest cohesivity -- spreads most widely through tissue

D. Highest water content -- most hydrating result

Q10. The 5-5-5 Rule applies to which product and what does it describe?(Required)

A. Juvederm Voluma -- 5 injections, 5mm depth, 5-week intervals

B. Sculptra -- dilute with 5mL water, wait 5 minutes, mix for 5 minutes before injection

C. Radiesse -- 5-point injection technique for cheek contour

D. Belotero -- 5 passes per zone at 5mm spacing for optimal integration

Q11. Why is Belotero Balance preferred for superficial fine lines near the eyes?

A. It contains the highest G-prime of any HA filler

B. Its polydensified matrix integrates evenly with very low Tyndall effect risk in thin-skin areas

C. It is the only filler that does not cause bruising

D. It lasts 3+ years without retreatment

Q12. How long should aspiration be held before filler injection to detect intravascular placement?(Required)

A. 0.5 seconds -- just enough to check for flash

B. 2+ seconds -- sufficient time to see blood return if intravascular

C. 5 seconds -- standard safety protocol for all injections

D. Aspiration is not recommended for filler -- proceed directly

Q13. Which facial zone has the highest risk of causing blindness from filler injection?(Required)

A. Nasolabial fold -- facial artery runs adjacent

B. Glabella and nose -- anastomosis with the ophthalmic artery

C. Cheek -- proximity to parotid gland vasculature

D. Jawline -- mental artery exits mental foramen nearby

Q14. A patient's filler results are diminishing rapidly at 3 months. What should be considered?(Required)

A. Increase injection depth next session

B. Switch to a permanent filler for longer-lasting results

C. Assess for hyaluronidase antibodies, enzyme degradation, or dilution errors; consider alternative HA

D. The product was counterfeit -- order from different supplier

Q15. Which technique is MOST appropriate for nasolabial fold correction?(Required)

A. Single bolus injection at the fold midpoint

B. Serial puncture or retrograde linear threading with blunt cannula

C. Push-ahead technique with sharp needle only

D. Fan technique from a single lateral entry point

Q16. For lip augmentation, filler should be placed at which anatomical depth?(Required)

A. Submucosal -- deep to all muscle

B. Periosteal -- at the maxillary bone level

C. Within or just above orbicularis oris -- no deeper than 3mm

D. Pure intradermal -- within vermillion skin only

Q17. Livedo reticularis 2 hours after NLF filler represents which vascular occlusion stage?(Required)

A. Stage 1 Blanching -- still highly reversible with immediate intervention

B. Stage 2 Livedo Reticularis -- progression of capillary obstruction; hyaluronidase still effective

C. Stage 3 Pustular -- bacterial invasion of ischemic tissue

D. Stage 5 Devitalized -- tissue is past the point of recovery

Q18. Juvederm Voluma XC is FDA-approved for which specific indication?(Required)

A. Lip augmentation in adults 21+

B. Midface volume augmentation in adults 21+

C. Periorbital tear trough correction

D. Glabellar line treatment with filler

Q19. Which patient is an ABSOLUTE contraindication for HA filler treatment?(Required)

A. Patient on baby aspirin 81mg for cardiovascular protection

B. Patient with prior anaphylaxis to HA or lidocaine (filler components)

C. Patient who had Botox 4 weeks ago in the forehead

D. Q20. A firm nodule at the injection site 3 weeks post-filler is MOST likely which complication?

Q20. A firm nodule at the injection site 3 weeks post-filler is MOST likely which complication?(Required)

A. Permanent scar tissue -- refer to dermatologic surgery

B. Delayed inflammatory nodule or biofilm -- may require hyaluronidase, antibiotics, or corticosteroid injection

C. Normal HA integration -- reassure and monitor without intervention

D. Bruising organizing into a hematoma -- apply pressure only

This field is hidden when viewing the form

Total

Dermal Filler Injectable Training for Registered Nurses - Quiz